DrugPatentWatch Database Preview
Details for Patent: 5,856,529
Email this page to a colleague
Which drugs does patent 5,856,529 protect, and when does it expire?
Patent 5,856,529 protects HETLIOZ and HETLIOZ LQ and is included in two NDAs.
This patent has thirty-one patent family members in twenty-four countries.
Summary for Patent: 5,856,529
| Title: | Benzofuran and dihydrobenzofuran melatonergic agents |
| Abstract: | Novel derivatives of benzofuran and dihydrobenzofuran are provided which are useful as melatonergic agents. |
| Inventor(s): | Catt; John D. (Southington, CT), Johnson; Graham (Madison, CT), Keavy; Daniel J. (Killingworth, CT), Mattson; Ronald J. (Meriden, CT), Parker; Michael F. (Middletown, CT), Takaki; Katherine S. (Middletown, CT), Yevich; Joseph P. (Southington, CT) |
| Assignee: | Bristol-Myers Squibb Company (Princeton, NJ) |
| Application Number: | 08/987,478 |
|
Patent Claim Types: see list of patent claims | Compound; Use; Composition; |
Drugs Protected by US Patent 5,856,529
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Vanda Pharms Inc | HETLIOZ | tasimelteon | CAPSULE;ORAL | 205677-001 | Jan 31, 2014 | RX | Yes | Yes | ⤷ Try it Free | ⤷ Try it Free | Y | Y | TREATMENT OF NON-24 HOUR SLEEP-WAKE DISORDER BY ADMINISTERING TASIMELTEON | ⤷ Try it Free | ||
| Vanda Pharms Inc | HETLIOZ | tasimelteon | CAPSULE;ORAL | 205677-001 | Jan 31, 2014 | RX | Yes | Yes | ⤷ Try it Free | ⤷ Try it Free | Y | Y | TREATMENT OF NIGHTTIME SLEEP DISTURBANCES IN SMITH-MAGENIS SYNDROME BY ADMINISTERING TASIMELTEON | ⤷ Try it Free | ||
| Vanda Pharms Inc | HETLIOZ LQ | tasimelteon | SUSPENSION;ORAL | 214517-001 | Dec 1, 2020 | RX | Yes | Yes | ⤷ Try it Free | ⤷ Try it Free | Y | Y | TREATMENT OF NIGHTTIME SLEEP DISTURBANCES IN SMITH-MAGENIS SYNDROME BY ADMINISTERING TASIMELTEON | ⤷ Try it Free | ||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 5,856,529
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Argentina | 010346 | ⤷ Try it Free | |||
| Austria | 281833 | ⤷ Try it Free | |||
| Australia | 5598598 | ⤷ Try it Free | |||
| Australia | 719994 | ⤷ Try it Free | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
